This podcast reviews a case-based discussion on managing age-related macular degeneration (AMD), a leading cause of blindness among older adults, particularly those enrolled in Medicare Advantage plans. Experts review the progression of AMD, key diagnostic tools, and the importance of timely anti-VEGF therapy to prevent vision loss. The conversation highlights payer considerations, including step therapy requirements, treatment burden, and long-term cost implications. It also addresses challenges such as healthcare access in rural areas and potential strategies for improving patient adherence and outcomes. The discussion underscores the need for balanced policies that optimize clinical efficacy and economic sustainability.

This activity is certified for CME/CNE/CPE credit. To participate and earn 

credit, visit us at https://www.managedcareeye.com/amd-case-challenge-ce/.